0001911051-22-000003.txt : 20220829 0001911051-22-000003.hdr.sgml : 20220829 20220829215710 ACCESSION NUMBER: 0001911051-22-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220825 FILED AS OF DATE: 20220829 DATE AS OF CHANGE: 20220829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fralick Celeste Rachelle CENTRAL INDEX KEY: 0001911051 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 221212791 MAIL ADDRESS: STREET 1: 2801 MESA ROAD CITY: LUBBOCK STATE: TX ZIP: 79403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-08-25 0 0000926617 Aspira Women's Health Inc. AWH 0001911051 Fralick Celeste Rachelle C/O ASPIRA WOMEN'S HEALTH INC. 12117 BEE CAVES RD, BLDG 3-100 AUSTIN TX 78738 1 0 0 0 Common Stock 2022-08-25 4 P 0 6667 A 102945 D Warrant (right to buy) 0.88 2022-08-25 4 P 0 6667 A 2022-08-25 2027-08-25 Common stock, par value $0.001 6667 6667 D Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit. Total reflects the adjustment of 3,393 shares of common stock previously reported as part of a restricted stock unit grant made on March 31, 2022. /s/ Celeste Fralick 2022-08-29